Oral and transcutaneous pharmacologic agents in the treatment of impotence.
The pharmacologic treatment of erectile failure is now a reality. However, current agents have major drawbacks. Some require invasive administration, whereas others offer only marginal effect. The use of hormones should be limited to well-documented cases of endocrine dysfunction. Oral and transcutaneous agents remain experimental, but new drugs are under investigation and show early encouraging results.
D000279:Administration, Cutaneous; D000284:Administration, Oral; D002986:Clinical Trials as Topic; D004700:Endocrine System Diseases / Q000150:complications / Q000188:drug therapy; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D005996:Nitroglycerin / Q000627:therapeutic use; D010410:Penile Erection / Q000187:drug effects; D015016:Yohimbine / Q000627:therapeutic use
D015016:Yohimbine; D005996:Nitroglycerin